Differential Detection of Single-Chain and Two-Chain Urokinase-Type Plasminogen Activator by a New Immunoadsorbent-Amidolytic Assay (IAA)

Summary

A new immunoadsorbent-amidolytic assay (IAA) for the specific differential detection of two-chain urokinase-type plasminogen activator (tcu-PA) and its single-chain precursor (scu-PA) in cell culture supernatants has been developed. The assay combines the selectivity of immunoassays with the specificity of enzyme activity assays exploiting both the antigenic and enzymatic properties of the two proteins. tcu-PA and scu-PA are selectively immunoadsorbed on the wells of a microtiterplate coated with the monoclonal antibody 5B4 and tested for enzymatic activity before and after activation by plasmin treatment. Both proteins are determined with similar efficiency since overlapping dose-response curves were obtained in the range between 12.5-200 ng/ml. The assay has been used to determine tcu-PA and scu-PA in A431 human epidermoid carcinoma cell supernatants. The analytical recoveries for tcu-PA and scu-PA added to A431 cell supernatants were 95.2% and 96.9% respectively. The intra- and inter-assay variations (CV) were 5.5% and 9.0% for tcu-PA and 9.7% and 9.8% for scu-PA respectively.

Key words

Urokinase - Pro-urokinase - Plasminogen activator - Fibrinolysis - Monoclonal antibody - Immunoassay

• References

• 1 Astrup T. Fibrinolysis: an overview. In: Progress in chemical fibrinolysis and thrombolysis Davidson JF, Rowan RM, Samana MM, Desnoyers PC. (eds). Vol 3 1-57 Raven Press; New York: 1978
• 2 Williams JR B. Fibrinolytic activity of urine. Br J Exp Pathol 1951; 32: 530-537
• 3 Günzler W, Steffens G, Ötting F, Kim SM, Frankus E, Flohe L. The primary structure of high molecular mass urokinase from human urine. The complete aminoacid sequence of the A-chain. Hoppe-Seyler’s Z Physiol Chem 1982; 363: 1155-1165
• 4 Flusain SS, Gurewich V, Lipinski B. Purification and partial characterization of a single-chain high-molecular-weight form of urokinase from human urine. Arch Biochem Biophys 1983; 220: 31-38
• 5 Stump DC, Thienpont M, Collen D. Urokinase-related proteins in human urine. Isolation and characterization of single-chain urokinase (pro-urokinase) and urokinase-inhibitor complex. J Biol Chem 1986; 261: 1267-1273
• 6 Wun TC, Schleuning WD, Reich E. Isolation and characterization of urokinase from human plasma. J Biol Chem 1982; 257: 3276-3283
• 7 Wun TC, Ossowski L, Reich E. A pro-enzyme form of human urokinase. J Biol Chem 1982; 257: 7262-7268
• 8 Nielsen LS, Hansen JG, Skriver L, Wilson EL, Kaltoff K, Zeuthen J, Dano K. Purification of zymogen to plasminogen activator from human glyoblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry 1982; 21: 6410-6415
• 9 Sumi H, Maruyama M, Matsuo O, Mihara H, Toki N. High fibrin-binding and thrombolytic properties of single polypeptide chain high molecular weight urokinase. Thromb Haemostas 1982; 47: 297
• 10 Kohno T, Hopper P, Lillquist JS, Suddith RL, Greenlee R, Moir DT. Kidney plasminogen activator: a precursor form of human urokinase with high fibrin affinity. Biotechnology 1984; 2: 628-634
• 11 Eaton DL, Scott RW, Baker JB. Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin. J Biol Chem 1984; 259: 6241
• 12 Stump DC, Lijnen HR, Collen D. Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures. J Biol Chem 1986; 261: 1274-1278
• 13 Corti A, Nolli ML, Soffientini A, Cassani G. Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells. Thromb Haemostas 1986; 56: 219-224
• 14 Holmes WE, Pennica D, Blaber M, Rey MW, Guenzler WA, Steffens GJ, Heyneker HL. Cloning and expression of the gene for pro-urokinase in Escherichia coli. Biotechnology 1985; 3: 923-929
• 15 Kasai S, Arimura H, Nishida M, Suyama T. Primary structure of single-chain pro-urokinase. J Biol Chem 1985; 260: 12382-12389
• 16 Kasai S, Arimura H, Nishida M, Suyama T. Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin. J Biol Chem 1985; 260: 12377-12381
• 17 Gurewich V, Pannell R, Lovie S, Kelley P, Suddith RL, Greenlee R. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). J Clin Invest 1984; 73: 1731-1739
• 18 Zamarron C, Lijnen HR, Van Hoef B, Collen D. Biological and thrombolytic properties of proenzyme and active forms of human urokinase. I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinase obtained from human urine or by recombinant DNA technology. Thromb Haemostas 1984; 52: 19-23
• 19 Huber K, Kircheimer J, Binder R. Characterization of a specific antihuman urokinase antibody: development of a sensitive competition radioimmunoassay for urokinase-antigen. J Lab Clin Med 1984; 103: 684-694
• 20 Vetterlein D, Bell TE, Young PL, Roblin R. Immunological quantitation and immunoadsorption of urokinase-like plasminogen activator secreted by human cells. J Biol Chem 1980; 255: 3665-3672
• 21 Herion P, Portetelle D, Franssen JD, Urbain J, Bollen A. Solid-phase enzyme immunoassay of urokinase using monoclonal antibodies. Biosci Rep 1983; 3: 381-388
• 22 Asted B, Holmberg L, Lecander I, Thorell J. Radioimmunoassay of urokinase for quantification of plasminogen activators released in ovarian tumor cultures. Eur J Cancer 1981; 17: 239
• 23 Nolli ML, Corti A, Soffientini A, Cassani G. A monoclonal antibody that recognizes the receptor-binding region of human urokinase plasminogen activator. Thromb Haemostas 1986; 56: 214-218
• 24 Claeson G, Friberger P, Knos M, Eriksson E. Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase. Haemostasis 1978; 7: 76-78